You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Clinical Evaluation of a Rebreathing Adsorber Mask to Facilitate Recovery from Vo

    SBC: Axon Medical Inc            Topic: N/A

    DESCRIPTION (provided by applicant): After surgery patients are transferred to a post anesthesia care unit to fully recover from anesthesia. There is a much higher chance of an adverse clinical event occurring during this recovery time (24%) than in the op erating room because patients are not as closely monitored. Airway obstruction is the most frequent complication. Patients with a critical resp ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Minimally-Invasive Image-Guided Therapy for Cancer Treatment

    SBC: CONTRADYN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term objective of this research is to develop a technology and eventually a minimally-invasive commercial system for image-guided photodynamic therapy for cancer. This is certainly in keeping with NCI's focus o n imaging in vivo for cancer screening, diagnosis, progression, image-guide therapy, treatment monitoring, and recurrence. In studies conducted ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  3. Methylerythritol Phosphate Pathway-Specific Natural Products as Antibacterials

    SBC: ECHELON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term objective of this project is to identify a new class of antibiotics targeting the methylerythritol phosphate (MEP) pathway, a novel pathway essential for the viability of all Gram-negative and many Gram- p ositive bacteria. Gram-negative bacteria are responsible for more than half of hospital acquired (nosocomial) infections which cost an estimate ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Discovery of Inositol(1,4,5)trisphosphate Receptor Inhibitors

    SBC: ECHELON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Stroke has become a significant cause of mortality and morbidity among elderly people in industrialized countries. To address the growing burden of health care costs and the immeasurable emotional toll on families as we ll as affected individuals, new pharmacological agents for prevention and treatment are desperately needed. Oxygen deprivation and oxidative st ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  5. Fluorogenic Assays for Measuring the Activity of Ceramidase and Sphingomyelinase

    SBC: ECHELON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Sphingolipids are a class of lipids that have important roles as structural components of cell membranes yet are also key signaling molecules involved in numerous cellular processes such as apoptosis, cell survival, dif ferentiation, motility, and growth. The levels of the various sphingolipids are kept in balance by metabolizing enzymes and disruptions by abno ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Methylerythritol Phosphate Pathway Inhibitors Targeting Gram-Negative Infections

    SBC: ECHELON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term objective of this project is to identify a new class of antibiotics targeting an underexploited pathway essential for the viability of all Gram-negative bacteria, the methylerythritol phosphate (MEP) pathw ay. Gram-negative bacteria are responsible for more than half of hospital acquired (nosocomial) infections which cost an estimated 5 billion d ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Snapback Primers for Genotyping and Mutation Scanning

    SBC: IDAHO TECHNOLOGY            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this Fast-Track STTR is to develop a simple, inexpensive, closed-tube PCR method for genotyping and sequence variant scanning. Instead of covalently-labeled probes, one of two primers includes a tail w ith a probe element. After asymmetric PCR, this tail anneals internally to the same strand, snapping back , to form a stem/loop structure. Bot ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Snapback Primers for Genotyping and Mutation Scanning

    SBC: IDAHO TECHNOLOGY            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this Fast-Track STTR is to develop a simple, inexpensive, closed-tube PCR method for genotyping and sequence variant scanning. Instead of covalently-labeled probes, one of two primers includes a tail w ith a probe element. After asymmetric PCR, this tail anneals internally to the same strand, snapping back , to form a stem/loop structure. Bot ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  9. FilmArray High Resolution Melting Detection of Mutations Causing Cystic Fibrosis

    SBC: IDAHO TECHNOLOGY            Topic: N/A

    DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is an autosomal recessive, life-shortening disease that affects ~30,000 patients in the U.S., while there are estimated 10 million symptomless carriers in the U.S. (www.cff.org). Approximately one in 2,500-3,300 newborns in the U.S. have CF, however newborn screening is mandated in only 39 states. The gene mutated is the cystic fibrosis t ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Wireless Subdural Electrode Array

    SBC: RIPPLE LLC            Topic: N/A

    DESCRIPTION (provided by applicant): In this translational SBIR program, we will develop a totally implantable, wireless, subdural electrode grid for short-term cortical EEG monitoring (less than 30 days). This device will be based upon novel manufacturin g processes that will allow synthesis of the wireless implants with integrated electronics at low cost and prices that are competitive with exi ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government